New York State Common Retirement Fund’s Corbus Pharmaceuticals CRBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,100
Closed -$21.2K 3225
2025
Q1
$21.2K Hold
4,100
﹤0.01% 2966
2024
Q4
$47.8K Hold
4,100
﹤0.01% 2868
2024
Q3
$85.3K Hold
4,100
﹤0.01% 2663
2024
Q2
$186K Buy
+4,100
New +$172K ﹤0.01% 2462
2021
Q3
Sell
-20
Closed -$1K 3375
2021
Q2
$1K Sell
20
-2,023
-99% -$112K ﹤0.01% 3384
2021
Q1
$121K Hold
2,043
﹤0.01% 3005
2020
Q4
$77K Hold
2,043
﹤0.01% 3116
2020
Q3
$110K Buy
2,043
+416
+26% +$75.3K ﹤0.01% 2883
2020
Q2
$409K Hold
1,627
﹤0.01% 2314
2020
Q1
$256K Hold
1,627
﹤0.01% 2341
2019
Q4
$266K Hold
1,627
﹤0.01% 2596
2019
Q3
$238K Hold
1,627
﹤0.01% 2676
2019
Q2
$338K Hold
1,627
﹤0.01% 2558
2019
Q1
$339K Hold
1,627
﹤0.01% 2482
2018
Q4
$285K Hold
1,627
﹤0.01% 2544
2018
Q3
$368K Hold
1,627
﹤0.01% 2559
2018
Q2
$246K Hold
1,627
﹤0.01% 2780
2018
Q1
$298K Hold
1,627
﹤0.01% 2581
2017
Q4
$346K Buy
1,627
+584
+56% +$125K ﹤0.01% 2519
2017
Q3
$224K Hold
1,043
﹤0.01% 2717
2017
Q2
$197K Buy
+1,043
New +$205K ﹤0.01% 2847

Other funds holding CRBP

New York State Common Retirement Fund's CRBP Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Corbus Pharmaceuticals (CRBP) in Q2 2025, closing a stake of 4,100 shares — an estimated $21.2K sold.

New York State Common Retirement Fund first reported a position in CRBP in Q2 2017 and held it in 21 quarters. The position peaked at $409K in Q2 2020. 80 funds tracked by Wall St. Rank hold CRBP as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Corbus Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 4,100 Corbus Pharmaceuticals shares in Q2 2025, an estimated $21.2K.
  • New York State Common Retirement Fund first reported a position in Corbus Pharmaceuticals in Q2 2017 and held it in 21 quarters.
  • New York State Common Retirement Fund's Corbus Pharmaceuticals position peaked at $409K in Q2 2020.
  • 80 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.